Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Rasburicase, sold under the brand name Elitek in the US and Fasturtec in the EU, is a medication that helps to clear uric acid from the blood. It is a recombinant version of urate oxidase, an enzyme that metabolizes uric acid to allantoin. Urate oxidase is known to be present in many mammals but does not naturally occur in humans. Rasburicase is produced…
Community, Culture & Applications
Explore the main themes, entities and connections around Rasburicase. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
acid uric administration urate oxidase patients mg elitek 15 kg blood adult pediatric strain reconstitution pharmacokinetics name us fasturtec eu
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Rasburicase | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Rasburicase | ATC code | V03AF07 (WHO) | 1.00 | infobox |
| Rasburicase | Bioavailability | N/A | 1.00 | infobox |
| Rasburicase | CAS Number | 134774-45-1 Y | 1.00 | infobox |
| Rasburicase | ChEMBL | ChEMBL1201594 N | 1.00 | infobox |
| Rasburicase | ChemSpider | none | 1.00 | infobox |
| Rasburicase | DrugBank | DB00049 Y | 1.00 | infobox |
| Rasburicase | ECHA InfoCard | 100.207.686 | 1.00 | infobox |
| Rasburicase | Elimination half-life | 18 hrs | 1.00 | infobox |
| Rasburicase | Formula | C1521H2381N417O461S7 | 1.00 | infobox |
| Rasburicase | IUPHAR/BPS | 7467 | 1.00 | infobox |
| Rasburicase | KEGG | D05704 | 1.00 | infobox |
| Rasburicase | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Rasburicase | Legal status | US: ℞-only | 1.00 | infobox |
| Rasburicase | Legal status | EU: Rx-only | 1.00 | infobox |
| Rasburicase | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Rasburicase | License data | US DailyMed: Rasburicase | 1.00 | infobox |
| Rasburicase | Molar mass | 34109.66 g·mol−1 | 1.00 | infobox |
| Rasburicase | Pregnancy category | AU: B2 | 1.00 | infobox |
| Rasburicase | Routes of administration | Intravenous infusion | 1.00 | infobox |
| Rasburicase | Trade names | Elitek, Fasturtec | 1.00 | infobox |
| Rasburicase | UNII | 08GY9K1EUO | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.